Andrew D Flapan
Overview
Explore the profile of Andrew D Flapan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chapman A, Russell-Dalton A, Holland J, Flapan A
Eur Heart J Case Rep
. 2023 Jun;
7(6):ytad229.
PMID: 37275435
Background: Transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of severe aortic stenosis, but is still associated with a risk of major vascular complication. Case Summary: An elective transfemoral...
2.
Bing R, Gu H, Chin C, Fang L, White A, Everett R, et al.
Heart
. 2020 Apr;
106(16):1236-1243.
PMID: 32345658
Objective: First-phase ejection fraction (EF1) is a novel measure of early left ventricular systolic dysfunction. We investigated determinants of EF1 and its prognostic value in aortic stenosis. Methods: EF1 was...
3.
Mead G, Elder A, Flapan A, Cordina J
Cochrane Database Syst Rev
. 2017 Nov;
11:CD002903.
PMID: 29140555
Background: Atrial fibrillation increases stroke risk and adversely affects cardiovascular haemodynamics. Electrical cardioversion may, by restoring sinus rhythm, improve cardiovascular haemodynamics, reduce the risk of stroke, and obviate the need...
4.
Moss A, Pessotto R, Flapan A
Heart
. 2017 Nov;
104(3):273-274.
PMID: 29101266
Question: Which of the following diagnoses best explains this presentation?Ankylosing spondylitisTakayasu arteritisSalmonellosisIgG4-related aortitisGiant cell aortitis.
5.
Hunter A, Shah A, Langrish J, Raftis J, Lucking A, Brittan M, et al.
Circulation
. 2017 Apr;
135(14):1284-1295.
PMID: 28373523
Background: Rates of myocardial infarction in firefighters are increased during fire suppression duties, and are likely to reflect a combination of factors including extreme physical exertion and heat exposure. We...
6.
Moss A, Dweck M, Flapan A
Heart
. 2016 Sep;
103(6):474.
PMID: 27634411
Clinical Introduction: A 33-year-old man with no history of coronary artery disease presented to the rapid access cardiology clinic with an episode of atypical anginal chest pain. He had a...
7.
Milner T, Viner A, MacKinnon A, Sethi T, Flapan A
Acta Cardiol
. 2015 Feb;
69(6):595-602.
PMID: 25643429
Objective: Galectin-3 is a pro-inflammatory, pro-fibrotic molecule implicated in the pathogenesis of heart failure, and associated with poor prognostic outcome. When measured following ST-elevation myocardial infarction (STEMI), a high plasma...
8.
Hunter A, Unosson J, Bosson J, Langrish J, Pourazar J, Raftis J, et al.
Part Fibre Toxicol
. 2014 Dec;
11:62.
PMID: 25487196
Background: Myocardial infarction is the leading cause of death in fire fighters and has been linked with exposure to air pollution and fire suppression duties. We therefore investigated the effects...
9.
Dweck M, Toor I, Flapan A, Fox K, Newby D
Expert Rev Cardiovasc Ther
. 2014 Jan;
12(2):131-4.
PMID: 24382061
The assessment of myocardial ischemia represents a cornerstone in our approach to coronary artery disease. Indeed many of the clinical decisions we make revolve around the results of stress testing,...
10.
Joshi N, Vesey A, Williams M, Shah A, Calvert P, Craighead F, et al.
Lancet
. 2013 Nov;
383(9918):705-13.
PMID: 24224999
Background: The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We used...